Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Cahn

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Acta Gastroenterologica Latinoamericana|March 4, 2005
[Endoscopic approach in HIV infected-patients with upper gastrointestinal symptoms]Martín Alejandro Olmos, Ana Fanín, Valentina Araya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination StudyGraeme J Moyle, Edwin DeJesus, Pedro Cahn, et al.
World Journal of Hepatology|September 28, 2017
CD4<sup>+</sup> T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patientsNatalia Laufer, Diego Ojeda, María Laura Polo, et al.
Antiviral Therapy|January 30, 2003
Venous and arterial blood lactate in HIV-infected patientsCarlos Zala, Marianne Harris, Claudia Ochoa, et al.
Obstetrics and Gynecology|June 2, 2007
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sitesJennifer S Read, Pedro Cahn, Marcelo Losso, et al.
Lancet (London, England)|December 14, 2002
Time to act: global apathy towards HIV/AIDS is a crime against humanityRobert Hogg, Pedro Cahn, Elly T Katabira, et al.
AIDS (London, England)|September 22, 2007
The intestinal mucosa as a reservoir of HIV-1 infection after successful HAARTLiliana Belmonte, Martin Olmos, Ana Fanin, et al.
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
Journal of Virology|June 20, 2002
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failureGustavo H Kijak, Viviana Simon, Peter Balfe, et al.
Lancet (London, England)|February 26, 2008
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?Edward J Mills, William A Schabas, Jimmy Volmink, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Acta Gastroenterologica Latinoamericana|March 4, 2005
[Endoscopic approach in HIV infected-patients with upper gastrointestinal symptoms]Martín Alejandro Olmos, Ana Fanín, Valentina Araya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination StudyGraeme J Moyle, Edwin DeJesus, Pedro Cahn, et al.
World Journal of Hepatology|September 28, 2017
CD4<sup>+</sup> T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patientsNatalia Laufer, Diego Ojeda, María Laura Polo, et al.
Antiviral Therapy|January 30, 2003
Venous and arterial blood lactate in HIV-infected patientsCarlos Zala, Marianne Harris, Claudia Ochoa, et al.
Obstetrics and Gynecology|June 2, 2007
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sitesJennifer S Read, Pedro Cahn, Marcelo Losso, et al.
Lancet (London, England)|December 14, 2002
Time to act: global apathy towards HIV/AIDS is a crime against humanityRobert Hogg, Pedro Cahn, Elly T Katabira, et al.
AIDS (London, England)|September 22, 2007
The intestinal mucosa as a reservoir of HIV-1 infection after successful HAARTLiliana Belmonte, Martin Olmos, Ana Fanin, et al.
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
Journal of Virology|June 20, 2002
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failureGustavo H Kijak, Viviana Simon, Peter Balfe, et al.
Lancet (London, England)|February 26, 2008
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?Edward J Mills, William A Schabas, Jimmy Volmink, et al.
Pageof 21